MAR 11, 2021 10:49 PM PST

Patients Lack Confidence in Their Doctor's Understanding of Cannabis

WRITTEN BY: Angela Dowden

Thirty-five states in the USA now have medical cannabis programs and a 2017 National Academies of Sciences, Engineering, and Medicine report supported the therapeutic value of cannabinoids for chemotherapy induced nausea and vomiting, chronic pain, and multiple sclerosis-related spasticity.

But despite all this, it seems people still do not feel comfortable “admitting” to their mainstream physician that they are using medically prescribed cannabis according to a recent study published in Journal of Cannabis Research. Indeed, most state-registered users of medicinal cannabis lacked confidence that their primary care provider (PCP) possessed a sufficient understanding of the drug. 

Reporting on the experience of 275 medical cannabis patients in Michigan, the researchers from University of Michigan Medical School found that only 18 percent of participants rated their PCP’s knowledge about medical cannabis as very good or excellent and only 21 percent were very or completely confident in their PCP’s ability to integrate medical cannabis into their treatment. As a result, most subjects reported obtaining their medical cannabis recommendation from a doctor specializing in cannabis rather than from their primary care provider.

The survey also found that while 86 percent had substituted cannabis for pharmaceutical medications, over two-thirds of these patients reported some gap in their PCP’s knowledge of their substitution, and 44 percent reported that their PCP was currently unaware of their substitution.

“Our study highlights the need for better integration between medical cannabis and mainstream healthcare, including enhancing PCP education on cannabis, the endocannabinoid system, and the benefits, risks, and harms of cannabis in relevant therapeutic contexts,” the researchers wrote.

“Applying this guidance in clinical practice would give PCPs better tools to assess safety and effectiveness of currently available cannabinoid products and could quickly feed back into clinical practice. As numerous clinical trials are underway, consistently updating this practical guidance based on the most recent data is critical”.

 

Sources: BMC, High Times, NORML

About the Author
  • I'm a journalist and author with many year's experience of writing for both a consumer and professional audience, mostly on nutrition, health and medical prescribing. My background is food science and I'm a registered nutritionist.
You May Also Like
NOV 10, 2021
Genetics & Genomics
A Protein That Helps Mitochondria Get the Antioxidants They Need
NOV 10, 2021
A Protein That Helps Mitochondria Get the Antioxidants They Need
Energy can come at a cost. In the body, as energy is produced in our cells, those essential chemical reactions also gene ...
NOV 18, 2021
Genetics & Genomics
Some Gene Isoforms are Exclusively Expressed in the Brain
NOV 18, 2021
Some Gene Isoforms are Exclusively Expressed in the Brain
For simplicity's sake, it's easy to think of the genome as a set of instructions that cells use to create the pr ...
NOV 18, 2021
Microbiology
Bacteria Stressed by Antibiotics May Become 'Disrupted' & Survive to Thrive
NOV 18, 2021
Bacteria Stressed by Antibiotics May Become 'Disrupted' & Survive to Thrive
Antibiotics work against bacterial infections, and for years, experts have been warning clinicians and the public to pre ...
NOV 23, 2021
Immunology
Obesity Drives Inflammation, Puts Teeth at Risk
NOV 23, 2021
Obesity Drives Inflammation, Puts Teeth at Risk
Work by University at Buffalo researchers has identified a link between obesity and gum disease. As gum disease escalate ...
NOV 25, 2021
Cancer
Could an Anti-Cancer Drug Treat Diabetes?
NOV 25, 2021
Could an Anti-Cancer Drug Treat Diabetes?
Diabetes and cancer are two common diseases that share many similar risk factors. People with diabetes are also at& ...
NOV 30, 2021
Cannabis Sciences
Terpene-Mediated Modulation of Cannabinoid Activity
NOV 30, 2021
Terpene-Mediated Modulation of Cannabinoid Activity
A popular theory – the “entourage effect” – has been gaining traction amongst the cannabis scien ...
Loading Comments...